Drug Type Monoclonal antibody |
Synonyms |
Target |
Mechanism EFNB2 inhibitors(Ephrin B2 ligand inhibitors), VEGFR2 modulators(Vascular endothelial growth factor receptor 2 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | ES | - |